Persistence while on labeled maintenance dose among advanced therapy-na Ïve patients with ulcerative colitis initiated on ustekinumab or adalimumab

This study compared treatment persistence while on labeled maintenance dose among advanced therapy (ADT)-na ïve patients with UC on ustekinumab or adalimumab.

Source: Gastroenterology - January 25, 2024 Category: Gastroenterology Authors: Sumesh Kachroo, Maryia Zhdanava, Sabree Burbage, Porpong Boonmak, Aditi Shah, Jill Korsiak, Patrick Lefebvre, Caroline Kerner, Dominic Pilon Source Type: research